NIH experts discuss post-acute COVID-19 | National Institutes of Health - National Institutes of Health

 Many people who have COVID-19 make a full recovery and return to their baseline state of health; however, some people have symptoms or other sequelae weeks or months after initial SARS-CoV-2 infection.

These heterogeneous symptoms were the subject of the virtual “Workshop on Post-acute Sequelae of COVID-19” hosted on Dec.

2 and 4, 2020, by the National Institute of Allergy and Infectious Diseases (NIAID), in collaboration with other institutes and centers of the National Institutes of Health.

The constellation of symptoms and other effects experienced by those who do not return to their baseline state of health after COVID-19 has been referred to by many names, including post-acute sequelae of COVID-19 (PASC), and long or long-haul COVID.

People who do not return to their baseline state of health have diverse clinical conditions  that will require individualized and multidisciplinary approaches to treatment

Careful study of the virus and the immune response to infection may help researchers understand how manifestations of post-acute COVID-19 arise

Toward understanding COVID-19 recovery: National Institutes of Health workshop on postacute COVID-19

Emily Erbelding, director of the NIAID Division of Microbiology and Infectious Diseases (DMID), is available for comment

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses

About the National Institutes of Health (NIH):

National Institute of Allergy and Infectious Diseases (NIAID)